Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Withdrawn 2Recruiting 2Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2CNS 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Brain Neoplasms 1

Interventions

Cisplatin 98pembrolizumab 79Radiotherapy 49Carboplatin 41Magnetic Resonance Spectroscopy 37toripalimab 34Radiotherapy, Intensity-Modulated 34Gemcitabine 29Docetaxel 28Cetuximab 28Specimen Handling 26Surgical Procedures, Operative 23Paclitaxel 23Fluorouracil 22Radiation 20Nivolumab 20Biopsy 18Drug Therapy 17Chemoradiotherapy 17Blood Specimen Collection 17Capecitabine 15Standard of Care 14tislelizumab 13Surveys and Questionnaires 13Platinum 13camrelizumab 12nimotuzumab 11Immune Checkpoint Inhibitors 11130-nm albumin-bound paclitaxel 111,2-diaminocyclohexaneplatinum II citrate 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × fluoromisonidazole × Head & Neck × Clear all
NCT06087614 2025-01-17

DE-HyART

Rajiv Gandhi Cancer Institute & Research Center, India

Phase 2 Recruiting
124 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05996432 2024-09-23

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Recruiting
48 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡